|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01801 INNOVENT BIO
Nominal 
38.250 -1.650 (-4.135%) | 2022/12 - Final RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (2,024,843) | (307,688) | (1,664,473) | (1,011,827) |
| Net Cash from / (used in) Investing Activities | -- | (2,698,148) | (5,184,588) | (2,569,157) | 855,225 |
| Net Cash from / (used in) Financing Activities | -- | 5,003,361 | 4,912,121 | 2,109,315 | 4,433,863 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 280,370 | (580,155) | (2,124,315) | 4,277,261 |
| Cash & Cash Equivalents at beginning of period | -- | 1,276,178 | 2,425,806 | 4,524,854 | 183,761 |
| Effect of Foreign Exchange Rate Changes | -- | (197,140) | (569,473) | 25,267 | 63,832 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,359,408 | 1,276,178 | 2,425,806 | 4,524,854 |
| Remarks: | Real time quote last updated: 29/09/2023 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -139,149 |
| %Change | -85.360% |
| EPS / (LPS) | RMB -0.090 |
| NBV Per Share (¥) | RMB 6.999 |